Taste-Masked Flucloxacillin Powder Part 2: Formulation Optimisation Using the Mixture Design Approach and Storage Stability.

Yoo, Okhee; Salman, Sam; von Ungern-Sternberg, Britta S; Lim, Lee Yong

Yoo, Okhee; Salman, Sam; von Ungern-Sternberg, Britta S; Lim, Lee Yong.

Afiliação

Yoo O; Pharmacy, School of Allied Health, University of Western Australia, Perth, WA 6009, Australia.
Salman S; Clinical Pharmacology and Toxicology Unit, PathWest Laboratory Medicine, Perth, WA 6009, Australia.
von Ungern-Sternberg BS; Medical School, The University of Western Australia, Perth, WA 6009, Australia.
Lim LY; Medical School, The University of Western Australia, Perth, WA 6009, Australia.

Pharmaceuticals (Basel) ; 16(8)2023 Aug 18.

Article em En | MEDLINE | ID: mdl-37631094

Palavras-chave

Eudragit EPO; flucloxacillin; mixture design; paediatric formulation; palmitic acid; taste-masked microparticles

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google